Breast cancer: Noninvasive and special situations

Robert W. Carlson, D. Craig Allred, Benjamin O. Anderson, Harold J. Burstein, W. Bradford Carter, Stephen B. Edge, John K. Erban, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Britt Marie Ljung, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lori J. Pierce, Elizabeth C. ReedMary Lou Smith, George Somlo, Neal S. Topham, John H. Ward, Eric P. Winer, Antonio C Wolff

Research output: Contribution to journalArticle

Abstract

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With few exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, no single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

Original languageEnglish (US)
Pages (from-to)1182-1207
Number of pages26
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume8
Issue number10
StatePublished - Oct 1 2010

Fingerprint

Breast Neoplasms
Clinical Trials
Physicians
Therapeutics
Patient Participation
Guidelines
Neoplasms

Keywords

  • Breast-conserving therapy
  • Ductal carcinoma in situ
  • Endocrine therapy
  • Lobular carcinoma in situ
  • Mastectomy
  • NCCN clinical practice guidelines
  • NCCN guidelines
  • Noninvasive breast cancer
  • Radiation therapy
  • Tamoxifen

ASJC Scopus subject areas

  • Oncology

Cite this

Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., ... Wolff, A. C. (2010). Breast cancer: Noninvasive and special situations. JNCCN Journal of the National Comprehensive Cancer Network, 8(10), 1182-1207.

Breast cancer : Noninvasive and special situations. / Carlson, Robert W.; Allred, D. Craig; Anderson, Benjamin O.; Burstein, Harold J.; Carter, W. Bradford; Edge, Stephen B.; Erban, John K.; Farrar, William B.; Forero, Andres; Giordano, Sharon Hermes; Goldstein, Lori J.; Gradishar, William J.; Hayes, Daniel F.; Hudis, Clifford A.; Ljung, Britt Marie; Marcom, P. Kelly; Mayer, Ingrid A.; McCormick, Beryl; Pierce, Lori J.; Reed, Elizabeth C.; Smith, Mary Lou; Somlo, George; Topham, Neal S.; Ward, John H.; Winer, Eric P.; Wolff, Antonio C.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 8, No. 10, 01.10.2010, p. 1182-1207.

Research output: Contribution to journalArticle

Carlson, RW, Allred, DC, Anderson, BO, Burstein, HJ, Carter, WB, Edge, SB, Erban, JK, Farrar, WB, Forero, A, Giordano, SH, Goldstein, LJ, Gradishar, WJ, Hayes, DF, Hudis, CA, Ljung, BM, Marcom, PK, Mayer, IA, McCormick, B, Pierce, LJ, Reed, EC, Smith, ML, Somlo, G, Topham, NS, Ward, JH, Winer, EP & Wolff, AC 2010, 'Breast cancer: Noninvasive and special situations', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8, no. 10, pp. 1182-1207.
Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB et al. Breast cancer: Noninvasive and special situations. JNCCN Journal of the National Comprehensive Cancer Network. 2010 Oct 1;8(10):1182-1207.
Carlson, Robert W. ; Allred, D. Craig ; Anderson, Benjamin O. ; Burstein, Harold J. ; Carter, W. Bradford ; Edge, Stephen B. ; Erban, John K. ; Farrar, William B. ; Forero, Andres ; Giordano, Sharon Hermes ; Goldstein, Lori J. ; Gradishar, William J. ; Hayes, Daniel F. ; Hudis, Clifford A. ; Ljung, Britt Marie ; Marcom, P. Kelly ; Mayer, Ingrid A. ; McCormick, Beryl ; Pierce, Lori J. ; Reed, Elizabeth C. ; Smith, Mary Lou ; Somlo, George ; Topham, Neal S. ; Ward, John H. ; Winer, Eric P. ; Wolff, Antonio C. / Breast cancer : Noninvasive and special situations. In: JNCCN Journal of the National Comprehensive Cancer Network. 2010 ; Vol. 8, No. 10. pp. 1182-1207.
@article{eb37723967bd4f98b05565c0d5cf1b26,
title = "Breast cancer: Noninvasive and special situations",
abstract = "The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With few exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, no single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.",
keywords = "Breast-conserving therapy, Ductal carcinoma in situ, Endocrine therapy, Lobular carcinoma in situ, Mastectomy, NCCN clinical practice guidelines, NCCN guidelines, Noninvasive breast cancer, Radiation therapy, Tamoxifen",
author = "Carlson, {Robert W.} and Allred, {D. Craig} and Anderson, {Benjamin O.} and Burstein, {Harold J.} and Carter, {W. Bradford} and Edge, {Stephen B.} and Erban, {John K.} and Farrar, {William B.} and Andres Forero and Giordano, {Sharon Hermes} and Goldstein, {Lori J.} and Gradishar, {William J.} and Hayes, {Daniel F.} and Hudis, {Clifford A.} and Ljung, {Britt Marie} and Marcom, {P. Kelly} and Mayer, {Ingrid A.} and Beryl McCormick and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Smith, {Mary Lou} and George Somlo and Topham, {Neal S.} and Ward, {John H.} and Winer, {Eric P.} and Wolff, {Antonio C}",
year = "2010",
month = "10",
day = "1",
language = "English (US)",
volume = "8",
pages = "1182--1207",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "10",

}

TY - JOUR

T1 - Breast cancer

T2 - Noninvasive and special situations

AU - Carlson, Robert W.

AU - Allred, D. Craig

AU - Anderson, Benjamin O.

AU - Burstein, Harold J.

AU - Carter, W. Bradford

AU - Edge, Stephen B.

AU - Erban, John K.

AU - Farrar, William B.

AU - Forero, Andres

AU - Giordano, Sharon Hermes

AU - Goldstein, Lori J.

AU - Gradishar, William J.

AU - Hayes, Daniel F.

AU - Hudis, Clifford A.

AU - Ljung, Britt Marie

AU - Marcom, P. Kelly

AU - Mayer, Ingrid A.

AU - McCormick, Beryl

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Smith, Mary Lou

AU - Somlo, George

AU - Topham, Neal S.

AU - Ward, John H.

AU - Winer, Eric P.

AU - Wolff, Antonio C

PY - 2010/10/1

Y1 - 2010/10/1

N2 - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With few exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, no single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

AB - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and select the most appropriate option from among the available alternatives. With few exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, no single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient/physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients.

KW - Breast-conserving therapy

KW - Ductal carcinoma in situ

KW - Endocrine therapy

KW - Lobular carcinoma in situ

KW - Mastectomy

KW - NCCN clinical practice guidelines

KW - NCCN guidelines

KW - Noninvasive breast cancer

KW - Radiation therapy

KW - Tamoxifen

UR - http://www.scopus.com/inward/record.url?scp=78951490233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78951490233&partnerID=8YFLogxK

M3 - Article

C2 - 20971842

AN - SCOPUS:78951490233

VL - 8

SP - 1182

EP - 1207

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 10

ER -